Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. (Q53330387)
Jump to navigation
Jump to search
scientific article published in November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. |
scientific article published in November 2009 |
Statements
Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. (English)
Peter Caravan
1 reference
Josef Vymazal
Elmar Spuentrup
Gerardo Cardenas-Molina
Andrea J Wiethoff
Michael G Hartmann
Edward C Parsons
1 November 2009
44
11
697-704